Acrospire Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-47
| Closed | -$1K | – | 914 |
|
|
2017
Q2 | $1K | Sell |
47
-500
| -91% | -$10.6K | ﹤0.01% | 2100 |
|
|
2017
Q1 | $11K | Sell |
547
-4,558
| -89% | -$91.7K | 0.01% | 1844 |
|
|
2016
Q4 | $85K | Sell |
5,105
-5,295
| -51% | -$88.2K | 0.04% | 1049 |
|
|
2016
Q3 | $214K | Buy |
10,400
+5,100
| +96% | +$105K | 0.14% | 128 |
|
|
2016
Q2 | $162K | Buy |
5,300
+2,400
| +83% | +$73.4K | 0.12% | 164 |
|
|
2016
Q1 | $109K | Buy |
+2,900
| New | +$109K | 0.08% | 270 |
|